Roderick H. O'Reilly - Jul 13, 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Jul 13, 2023
Transactions value $
$0
Form type
4
Date filed
7/17/2023, 05:36 PM
Previous filing
Mar 2, 2023
Next filing
Jul 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Award $0 +21.6K $0.00 21.6K Jul 13, 2023 Common Stock 21.6K $4.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Unit ("RSU") is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSU will vest in full on the one-year anniversary of July 13, 2023, so long as the Reporting Person remains a director on such date.